Christina McEnery, APRN
Nurse Practitioner · Elmhurst, ILNPI 1346779022
Payments from drug & device makers
Across 131 payments — averaging $23.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$436
- Incyte Corporation$226
- Johnson & Johnson$213
- Lilly USA, LLC$208
- Seagen Inc.$208
- Bristol Myers Squibb$176
- plus $2K from 26 others
What the payments were for
- Speaking & faculty fees$301%
- Food & beverage$2,86094%
- Education$1655%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $436 |
| Incyte Corporation | 11 | $226 |
| Johnson & Johnson | 9 | $213 |
| Lilly USA, LLC | 9 | $208 |
| Seagen Inc. | 11 | $208 |
| Bristol Myers Squibb | 9 | $176 |
| Merck | 7 | $173 |
| Novartis | 6 | $153 |
| Amgen | 3 | $144 |
| Genentech USA, Inc. | 4 | $119 |
| Jazz Pharmaceuticals Inc. | 3 | $116 |
| Sanofi | 5 | $102 |
| E.r. Squibb & Sons, L.L.C. | 4 | $90 |
| Daiichi Sankyo Inc. | 3 | $82 |
| GSK | 4 | $81 |
| Exelixis Inc. | 4 | $76 |
| Pfizer | 3 | $75 |
| AbbVie | 2 | $44 |
| Gilead | 2 | $43 |
| Bayer | 2 | $43 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| BD | 1 | $30 |
| Shorla Oncology Inc. | 1 | $29 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $20 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| ADC Therapeutics America, Inc. | 1 | $18 |
| Epizyme, Inc. | 1 | $17 |
| Coherus Oncology, Inc. | 1 | $17 |
| Immunogen, Inc. | 1 | $15 |
| Pharmaand GmbH | 1 | $15 |
| Tolmar, Inc. | 1 | $15 |
How this compares
$3,055 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dexamethasone | 17 | $460 |
| Prochlorperazine Maleate | 38 | $341 |
| Acyclovir | 13 | $246 |
| Ondansetron Hcl | 25 | $136 |
| Prednisone | 15 | $84 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Elmhurst
- Erika VuckoChicago$417K
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Kristy LukeChicago$77K
- Yvonna OldakerFlossmoor$74K
- Heather PiercePekin$72K
- Dara McKinleyEvanston$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.